CD12681
Code | Size | Price |
---|
TAR-T25216-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25216-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25216-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CD12681 is an effective RORγ inverse agonist, preclinical Candidate for the topical therapy of psoriasis.
CAS:
1952239-59-6
Formula:
C25H33N3O4S
Molecular Weight:
471.62
Purity:
0.98
SMILES:
CC(C)CN(c1ccc(C)cc1C)S(=O)(=O)c1ccc2n(CC3CCOCC3)c(=O)[nH]c2c1
References
1. Ouvry G, Atrux-Tallau N, Bihl F,et al. Discovery and Characterization of CD12681, a Potent ROR? Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis. ChemMedChem. 2018 Feb 20;13(4):321-337. doi: 10.1002/cmdc.201700758. Epub 2018 Feb 6. PubMed PMID: 29327456.